zynrelef
heron therapeutics, b.v. - bupivacaine, meloxicam - smerte, postoperativ - anestetika - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.
evotaz
bristol-myers squibb pharma eeig - cobicistat, atazanavir - hiv-infeksjoner - antivirale midler til systemisk bruk - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 og 5.
hemangiol
pierre fabre medicament - propranolol hydroklorid - hemangiom - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
bupivacaine accord 5 mg/ ml
accord healthcare b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml
bupivacaine accord 2.5 mg/ ml
accord healthcare b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml
propofol-lipuro 20 mg/ ml
b. braun melsungen ag - propofol - injeksjons-/infusjonsvæske, emulsjon - 20 mg/ ml
pentocur 1 g
abcur ab - tiopentalnatrium - pulver til injeksjonsvæske, oppløsning - 1 g
pentocur 0.5 g
abcur ab - tiopentalnatrium - pulver til injeksjonsvæske, oppløsning - 0.5 g
ropivacain fresenius kabi 5 mg/ ml
fresenius kabi norge as - halden - ropivakainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 5 mg/ ml
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indikert for symptomatisk behandling av myotonia hos voksne pasienter med ikke-dystrophic myotonic lidelser.